241 related articles for article (PubMed ID: 26320861)
1. Small-Molecule Reactivation of Mutant p53 to Wild-Type-like p53 through the p53-Hsp40 Regulatory Axis.
Hiraki M; Hwang SY; Cao S; Ramadhar TR; Byun S; Yoon KW; Lee JH; Chu K; Gurkar AU; Kolev V; Zhang J; Namba T; Murphy ME; Newman DJ; Mandinova A; Clardy J; Lee SW
Chem Biol; 2015 Sep; 22(9):1206-16. PubMed ID: 26320861
[TBL] [Abstract][Full Text] [Related]
2. Reactivation of wild-type and mutant p53 by tryptophanolderived oxazoloisoindolinone SLMP53-1, a novel anticancer small-molecule.
Soares J; Raimundo L; Pereira NA; Monteiro Â; Gomes S; Bessa C; Pereira C; Queiroz G; Bisio A; Fernandes J; Gomes C; Reis F; Gonçalves J; Inga A; Santos MM; Saraiva L
Oncotarget; 2016 Jan; 7(4):4326-43. PubMed ID: 26735173
[TBL] [Abstract][Full Text] [Related]
3. Identification of a druggable protein-protein interaction site between mutant p53 and its stabilizing chaperone DNAJA1.
Tong X; Xu D; Mishra RK; Jones RD; Sun L; Schiltz GE; Liao J; Yang GY
J Biol Chem; 2021; 296():100098. PubMed ID: 33208462
[TBL] [Abstract][Full Text] [Related]
4. Selective killing of human breast cancer cells by the styryl lactone (R)-goniothalamin is mediated by glutathione conjugation, induction of oxidative stress and marked reactivation of the R175H mutant p53 protein.
Punganuru SR; Madala HR; Arutla V; Srivenugopal KS
Carcinogenesis; 2018 Dec; 39(11):1399-1410. PubMed ID: 30010803
[TBL] [Abstract][Full Text] [Related]
5. Small-molecule RETRA suppresses mutant p53-bearing cancer cells through a p73-dependent salvage pathway.
Kravchenko JE; Ilyinskaya GV; Komarov PG; Agapova LS; Kochetkov DV; Strom E; Frolova EI; Kovriga I; Gudkov AV; Feinstein E; Chumakov PM
Proc Natl Acad Sci U S A; 2008 Apr; 105(17):6302-7. PubMed ID: 18424558
[TBL] [Abstract][Full Text] [Related]
6. Mutant p53 reactivation by small molecules makes its way to the clinic.
Bykov VJ; Wiman KG
FEBS Lett; 2014 Aug; 588(16):2622-7. PubMed ID: 24768524
[TBL] [Abstract][Full Text] [Related]
7. Small-molecule modulators of p53 family signaling and antitumor effects in p53-deficient human colon tumor xenografts.
Wang W; Kim SH; El-Deiry WS
Proc Natl Acad Sci U S A; 2006 Jul; 103(29):11003-8. PubMed ID: 16835297
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effect of novel small chemical inhibitors of Snail-p53 binding in K-Ras-mutated cancer cells.
Lee SH; Shen GN; Jung YS; Lee SJ; Chung JY; Kim HS; Xu Y; Choi Y; Lee JW; Ha NC; Song GY; Park BJ
Oncogene; 2010 Aug; 29(32):4576-87. PubMed ID: 20531295
[TBL] [Abstract][Full Text] [Related]
9. Reactivation of mutant p53 by capsaicin, the major constituent of peppers.
Garufi A; Pistritto G; Cirone M; D'Orazi G
J Exp Clin Cancer Res; 2016 Sep; 35(1):136. PubMed ID: 27599722
[TBL] [Abstract][Full Text] [Related]
10. Andrographolide induces degradation of mutant p53 via activation of Hsp70.
Sato H; Hiraki M; Namba T; Egawa N; Baba K; Tanaka T; Noshiro H
Int J Oncol; 2018 Aug; 53(2):761-770. PubMed ID: 29845212
[TBL] [Abstract][Full Text] [Related]
11. Butein inhibits cancer cell growth by rescuing the wild-type thermal stability of mutant p53.
Song B; Wang J; Ren Y; Su Y; Geng X; Yang F; Wang H; Zhang J
Biomed Pharmacother; 2023 Jul; 163():114773. PubMed ID: 37156116
[TBL] [Abstract][Full Text] [Related]
12. Selective targeting p53
Lu W; Cheng F; Yan W; Li X; Yao X; Song W; Liu M; Shen X; Jiang H; Chen J; Li J; Huang J
Oncogene; 2017 Aug; 36(33):4719-4731. PubMed ID: 28394340
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of a C7-aryl piperlongumine derivative with potent antimicrotubule and mutant p53-reactivating properties.
Punganuru SR; Madala HR; Venugopal SN; Samala R; Mikelis C; Srivenugopal KS
Eur J Med Chem; 2016 Jan; 107():233-44. PubMed ID: 26599530
[TBL] [Abstract][Full Text] [Related]
14. DIMP53-1: a novel small-molecule dual inhibitor of p53-MDM2/X interactions with multifunctional p53-dependent anticancer properties.
Soares J; Espadinha M; Raimundo L; Ramos H; Gomes AS; Gomes S; Loureiro JB; Inga A; Reis F; Gomes C; Santos MMM; Saraiva L
Mol Oncol; 2017 Jun; 11(6):612-627. PubMed ID: 28296148
[TBL] [Abstract][Full Text] [Related]
15. Semi-Synthesis of Small Molecules of Aminocarbazoles: Tumor Growth Inhibition and Potential Impact on p53.
Long S; Loureiro JB; Carvalho C; Gales L; Saraiva L; Pinto MMM; Puthongking P; Sousa E
Molecules; 2021 Mar; 26(6):. PubMed ID: 33804175
[TBL] [Abstract][Full Text] [Related]
16. Small molecule restoration of wildtype structure and function of mutant p53 using a novel zinc-metallochaperone based mechanism.
Yu X; Blanden AR; Narayanan S; Jayakumar L; Lubin D; Augeri D; Kimball SD; Loh SN; Carpizo DR
Oncotarget; 2014 Oct; 5(19):8879-92. PubMed ID: 25294809
[TBL] [Abstract][Full Text] [Related]
17. Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations.
Li X; Wu JB; Chung LW; Huang WC
Oncotarget; 2015 Dec; 6(38):41018-32. PubMed ID: 26512780
[TBL] [Abstract][Full Text] [Related]
18. Discovery of a new small-molecule inhibitor of p53-MDM2 interaction using a yeast-based approach.
Leão M; Pereira C; Bisio A; Ciribilli Y; Paiva AM; Machado N; Palmeira A; Fernandes MX; Sousa E; Pinto M; Inga A; Saraiva L
Biochem Pharmacol; 2013 May; 85(9):1234-45. PubMed ID: 23428467
[TBL] [Abstract][Full Text] [Related]
19. Oxazoloisoindolinones with in vitro antitumor activity selectively activate a p53-pathway through potential inhibition of the p53-MDM2 interaction.
Soares J; Pereira NA; Monteiro Â; Leão M; Bessa C; Dos Santos DJ; Raimundo L; Queiroz G; Bisio A; Inga A; Pereira C; Santos MM; Saraiva L
Eur J Pharm Sci; 2015 Jan; 66():138-47. PubMed ID: 25312347
[TBL] [Abstract][Full Text] [Related]
20. Mechanical cues control mutant p53 stability through a mevalonate-RhoA axis.
Ingallina E; Sorrentino G; Bertolio R; Lisek K; Zannini A; Azzolin L; Severino LU; Scaini D; Mano M; Mantovani F; Rosato A; Bicciato S; Piccolo S; Del Sal G
Nat Cell Biol; 2018 Jan; 20(1):28-35. PubMed ID: 29255172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
